GlobeNewswire 9/24/2025 Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
TeleTrader 9/10/2025 Merck closes £1B London research hub
GlobeNewswire 8/28/2025 Gene and Oral Therapies Drive Urgency and Innovation in Retinal Care, Reshaping Ophthalmology’s Futu...
GlobeNewswire 8/18/2025 European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desm...
TeleTrader 7/29/2025 Merck's Q2 sales down by 2% to $15.8B
GlobeNewswire 7/19/2025 MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term S...
GlobeNewswire 7/18/2025 European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adul...
GlobeNewswire 7/16/2025 Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck ...
TeleTrader 7/9/2025 Merck confirms $10B acquisition of Verona
TeleTrader 7/9/2025 Verona jumps 18% on report of $10B Merck takeover bid
GlobeNewswire 7/8/2025 Certara Announces Expansion of Clinical Technology Collaboration with Merck
TMX Newsfile 5/1/2025 Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm
TeleTrader 4/29/2025 Merck to invest $1 billion in new US site
GlobeNewswire 4/28/2025 Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth ...
TeleTrader 4/24/2025 Merck's Q1 sales down 2% to $15.5 billion
GlobeNewswire 4/18/2025 MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term S...
GlobeNewswire 4/15/2025 Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeuti...
GlobeNewswire 4/13/2025 MRK Investors Have the Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, ...
GlobeNewswire 4/12/2025 MRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors with L...
GlobeNewswire 4/10/2025 Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors – Contact Levi & K...
GlobeNewswire 4/9/2025 MRK FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Merck & Co., Inc. Investors to Secure ...
GlobeNewswire 4/9/2025 INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Me...
GlobeNewswire 4/9/2025 World Leaders in Proteomics and Proteoform Biology to Convene at the 3rd International Top-Down Prot...
TMX Newsfile 4/8/2025 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
GlobeNewswire 4/7/2025 MRK FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Coun...